Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Eye (London, England)|June 19, 2024
The spectrum of giant cell arteritis through a rheumatology lensMuhammad Irfan Khalique, Mousindha Arjunan, Samuel Wood, et al.
Current Opinion in Rheumatology|March 15, 2014
Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitisSuzanne Arends, Anneke Spoorenberg, Elisabeth Brouwer, et al.
Clinical Rheumatology|March 31, 2021
Genetically predicted serum urate levels have no causal role on depression or other psychiatric disordersSizheng Steven Zhao, Yu Qian, Sarah L Mackie, et al.
Rheumatology Advances in Practice|January 5, 2026
Patient perspectives on life impact and unmet needs in giant cell arteritis and polymyalgia rheumatica: insights from social mediaSarah L Mackie, Pallavi Arun, Vandana Padmanabhan, et al.
Therapeutic Advances in Musculoskeletal Disease|August 2, 2026
Measurement of the impact of giant cell arteritis and treatment with glucocorticoids on health-related quality of lifeEmily Barnes, Olivia Beazer, Mwidimi Ndosi, et al.
Arthritis Research & Therapy|October 18, 2023
High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritisLiseth de Wolff, Suzanne Arends, Elisabeth Brouwer, et al.
RMD Open|February 12, 2022
Need and value of targeted immunosuppressive therapy in giant cell arteritisMaria Sandovici, Niels van der Geest, Yannick van Sleen, et al.
Rheumatology (Oxford, England)|May 24, 2024
Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomizationSizheng Steven Zhao, Sarah L Mackie, Susanna C Larsson, et al.
Rheumatology (Oxford, England)|December 4, 2023
Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association studyCharikleia Chatzigeorgiou, Jennifer H Barrett, Javier Martin, et al.
Pageof 27